Evotec AG announced that it has entered into a multi-year integrated drug discovery alliance with Genentech Inc., a wholly owned member of the Roche Group, to discover novel small molecule therapeutics.
The Alzheimer’s Drug Discovery Foundation (ADDF) has awarded a grant of $210,300 to Amicus Therapeutics to evaluate small-molecule, orally delivered pharmacological chaperone compounds as a novel approach for treating Alzheimer’s disease.
A new study by researchers from McGill University and the University of British Columbia shows that mice, like humans, express pain through facial expressions.
In findings that advance scientists' understanding of a whole class of inherited disorders, The Scripps Research Institute has shed light on a mechanism that enables a potential treatment for Gaucher's disease and other lysosomal storage diseases.
Pramipexole, a dopamine agonist, improves depressive symptoms in patients with Parkinson's disease (PD), and has the potential to become an important antidepressant treatment for these patients.
VBL Therapeutics announced positive preclinical results evaluating VB-201 for the treatment of psoriasis. VB-201 is a first-in-class, orally administered immune response modifier expected to reduce inflammation by targeting key pro-inflammatory cytokines.
Members of both SBS and ALA showed overwhelming support for uniting as Sections within the new inclusive organization -- the Society for Laboratory Automation and Screening.
New research shows for the first time that molecules called microRNA can silence genes that protect the genome from cancer-causing mutations.
A team of University of California, San Diego School of Medicine researchers has discovered that common intestinal bacteria appear to promote tumor growths in genetically susceptible mice, but that tumorigenesis can be suppressed if the mice are exposed to an inhibiting protein enzyme.
The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected from a growing number of collaborations between biotech firms in developing countries.
A jury in Las Vegas ordered two drug companies to pay a combined $500 million in punitive damages in the first of hundreds of civil cases stemming from a hepatitis C outbreak two years ago.
On June 15, some older people with high prescription drug costs will receive $250 to help fill a gap in Medicare's pharmaceutical benefits.
The cost of treating cancer in the United States nearly doubled over the past two decades, but expensive cancer drugs may not be the main reason why, according to a surprising new study.
Strand Life Sciences has entered into an agreement with the FDA to deliver the Genomics Reviewer Desktop (GRD), a solution to enable FDA reviewers to manage and analyze pharmacogenomic data submitted through its Voluntary Exploratory Data Submissions (VXDS) program.